Cargando…
Androgen receptor increases and negative expression of GCDFP-15 in primary ductal adenocarcinoma of the lacrimal gland: a case description
Autores principales: | Yang, Shideng, Chen, Wei, Chen, Wen, Sun, Guoping, Zhang, Ming, Fan, Yuxin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9929414/ https://www.ncbi.nlm.nih.gov/pubmed/36819271 http://dx.doi.org/10.21037/qims-22-312 |
Ejemplares similares
-
GCDFP-15, AR, and Her-2 as biomarkers for primary ductal adenocarcinoma of the lacrimal gland: a Chinese case and literature review
por: Zhu, Miao-Miao, et al.
Publicado: (2015) -
Evaluation of GATA3 and GCDFP15 Expression in Triple Negative Breast Cancers
por: Ahadi, Mahsa, et al.
Publicado: (2023) -
Lacrimal gland adenocarcinoma responding to checkpoint inhibition and androgen deprivation
por: Bulbul, Ajaz
Publicado: (2018) -
Adenocarcinoma in situ (ductal type) ex pleomorphic adenoma of the lacrimal gland
por: Fakhril-din, Zainab, et al.
Publicado: (2023) -
Immunoexpression of the GCDFP-15 Marker in Different Grades of Breast Carcinoma
por: Shirian, Faeze, et al.
Publicado: (2023)